Works by Gantz, Ira

Results: 51

Once-weekly oral antidiabetic agent and treatment satisfaction.

Published in:

2017

By:

Gantz, Ira;
Gantz, Ira On Behalf Of The Co-Authors

Publication type:

Letter

Long‐term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 583, doi. 10.1111/dom.16050

By:

Cosentino, Francesco;
Dagogo‐Jack, Samuel;
Frederich, Robert;
Cannon, Christopher P.;
Cherney, David Z. I.;
Mancuso, James P.;
Wynant, Willy;
Xing, Aiwen;
Gantz, Ira;
Cater, Nilo B.;
Pratley, Richard E.

Publication type:

Article

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691

By:

Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z. I.;
Cosentino, Francesco;
Liu, Jie;
Pong, Annpey;
Gantz, Ira;
Frederich, Robert;
Mancuso, James P.;
Pratley, Richard E.

Publication type:

Article

Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1640, doi. 10.1111/dom.14385

By:

Lingvay, Ildiko;
Greenberg, Michelle;
Gallo, Silvina;
Shi, Harry;
Liu, Jie;
Gantz, Ira

Publication type:

Article

A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1242, doi. 10.1111/dom.14331

By:

Kadowaki, Takashi;
Seino, Yutaka;
Kaku, Kohei;
Okamoto, Taro;
Kameya, Miho;
Sato, Asako;
Hirano, Tomona;
Oshima, Nobuyuki;
Gantz, Ira;
O'Neill, Edward A.;
Engel, Samuel S.

Publication type:

Article

Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2276, doi. 10.1111/dom.14150

By:

Pratley, Richard;
Dagogo‐Jack, Samuel;
Charbonnel, Bernard;
Patel, Shrita;
Hickman, Anne;
Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Ellison, Misoo C.;
Huyck, Susan;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

Efficacy and safety of ertugliflozin in East/Southeast Asian patients with type 2 diabetes mellitus.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 574, doi. 10.1111/dom.13931

By:

Liu, Jie;
Patel, Shrita;
Cater, Nilo B.;
Wu, Larry;
Huyck, Susan;
Terra, Steven G.;
Hickman, Anne;
Darekar, Amanda;
Pong, Annpey;
Gantz, Ira

Publication type:

Article

Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 781, doi. 10.1111/dom.13574

By:

Roussel, Ronan;
Duran‐García, Santiago;
Zhang, Yilong;
Shah, Suneri;
Darmiento, Carolyn;
Shankar, R. Ravi;
Golm, Gregory T.;
Lam, Raymond L. H.;
O'Neill, Edward A.;
Gantz, Ira;
Kaufman, Keith D.;
Engel, Samuel S.

Publication type:

Article

A randomized, placebo- and sitagliptin-controlled trial of the safety and efficacy of omarigliptin, a once-weekly dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1602, doi. 10.1111/dom.12988

By:

Gantz, Ira;
Okamoto, Taro;
Ito, Yuka;
Okuyama, Kotoba;
O'Neill, Edward A.;
Kaufman, Keith D.;
Engel, Samuel S.;
Lai, Eseng

Publication type:

Article

Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 ( DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 394, doi. 10.1111/dom.12832

By:

Goldenberg, Ronald;
Gantz, Ira;
Andryuk, Paula J.;
O'Neill, Edward A.;
Kaufman, Keith D.;
Lai, Eseng;
Wang, Yin Na;
Suryawanshi, Shailaja;
Engel, Samuel S.

Publication type:

Article

Clinical Trial: A Phase 2b Study to Evaluate the Efficacy and Safety of MK‐3655 in Individuals With Pre‐Cirrhotic MASH.

Published in:

Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 7, p. 1152, doi. 10.1111/apt.70038

By:

Raji, Annaswamy;
Gantz, Ira;
Crutchlow, Michael;
Flynn, Heather;
Xu, Lianzhe;
Rodgers, Anthony J.;
Krishnan, Radha;
Rizk, Matthew L.;
Hu, Shuai;
Kaufman, Keith D.;
Engel, Samuel S.

Publication type:

Article

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial.

Published in:

European Heart Journal, 2023, v. 44, n. 48, p. 5163, doi. 10.1093/eurheartj/ehad639

By:

Pandey, Ambarish;
Kolkailah, Ahmed A;
Cosentino, Francesco;
Cannon, Christopher P;
Frederich, Robert C;
Cherney, David Z I;
Dagogo-Jack, Samuel;
Pratley, Richard E;
Cater, Nilo B;
Gantz, Ira;
Mancuso, James P;
McGuire, Darren K

Publication type:

Article

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes.

Published in:

2015

By:

Sheu, Wayne H.-H.;
Gantz, Ira;
Chen, Menghui;
Suryawanshi, Shailaja;
Mirza, Arpana;
Goldstein, Barry J.;
Kaufman, Keith D.;
Engel, Samuel S.

Publication type:

journal article

A Randomized Trial of Lifestyle Modification and Taranabant for Maintaining Weight Loss Achieved With a Low-Calorie Diet.

Published in:

Obesity (19307381), 2010, v. 18, n. 12, p. 2301, doi. 10.1038/oby.2010.67

By:

Wadden, Thomas A.;
Fujioka, Ken;
Toubro, Soren;
Gantz, Ira;
Erondu, Ngozi E.;
Menghui Chen;
Suryawanshi, Shailaja;
Carofano, Wendy;
Johnson-Levonas, Amy O.;
Shapiro, Deborah R.;
Kaufman, Keith D.;
Heymsfield, Steven B.;
Amatruda, John M.

Publication type:

Article

Cloning of Canine Gastrin cDNA's Encoding Variant Amino Acid Sequences.

Published in:

Digestion, 1990, v. 46, n. S2, p. 99, doi. 10.1159/000200372

By:

Gantz, Ira;
Takeuchi, Toshiyuki;
Yamadaa, Tadataka

Publication type:

Article

Efficacy and safety of ertugliflozin across racial groups in patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Wu, Larry;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Efficacy and safety of ertugliflozin in Hispanic/Latino patients with type 2 diabetes mellitus.

Published in:

2020

By:

Liu, Jie;
Tarasenko, Lisa;
Pong, Annpey;
Huyck, Susan;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Ellison, Misoo C.;
Gantz, Ira;
Terra, Steven G.

Publication type:

journal article

Factors associated with the discontinuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) after initiation of insulin.

Published in:

2020

By:

Fernandes, Gail;
Matos, Joana E.;
Jaffe, Dena H.;
Beyer, Grace;
Yang, Lingfeng;
Iglay, Kristy;
Gantz, Ira;
Rajpathak, Swapnil

Publication type:

journal article

Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist.

Published in:

AAPS Journal, 2010, v. 12, n. 4, p. 537, doi. 10.1208/s12248-010-9212-2

By:

Li, Xiujiang (Susie);
Nielsen, Jace;
Cirincione, Brenda;
Li, Hankun;
Addy, Carol;
Wagner, John;
Hartford, Alan;
Erondu, Ngozi;
Gantz, Ira;
Morgan, Jerry;
Stone, Julie

Publication type:

Article

Efficacy and Safety of Intranasal Peptide YY<sub>3–36 </sub>for Weight Reduction in Obese Adults.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 5, p. 1754, doi. 10.1210/jc.2006-1806

By:

Gantz, Ira;
Erondu, Ngozi;
Mallick, Madhuja;
Musser, Bret;
Krishna, Rajesh;
Tanaka, Wesley K.;
Snyder, Karen;
Stevens, Cathy;
Stroh, Mark A.;
Haiyuan Zhu;
Wagner, John A.;
MacNeil, Douglas J.;
Heymsfield, Steven B.;
Amatruda, John M.

Publication type:

Article

Naturally Occurring Mutations in the Melanocortin Receptor 3 Gene Are Not Associated with Type 2 Diabetes Mellitus in French Caucasians.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 6, p. 2895, doi. 10.1210/jcem.86.6.7589

By:

HANI, EL HABIB;
DUPONT, SOPHIE;
DURAND, EMMANUELLE;
DINA, CHRISTIAN;
GALLINA, SOPHIE;
GANTZ, IRA;
FROGUEL, PHILIPPE

Publication type:

Article

Neuroendocrine Regulation by the Agouti/Agrp-Melanocortin System.

Published in:

Endocrine Research, 2000, v. 26, n. 4, p. 571, doi. 10.3109/07435800009048572

By:

Barsh, Greg;
Gunn, Teresa;
He, Lin;
Wilson, Brent;
Lu, Xinyun;
Gantz, Ira;
Watson, Stanley

Publication type:

Article

Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV.

Published in:

Diabetes Therapy, 2021, v. 12, n. 5, p. 1279, doi. 10.1007/s13300-021-01033-x

By:

Budoff, Matthew J.;
Davis, Timothy M. E.;
Palmer, Alexandra G.;
Frederich, Robert;
Lawrence, David E.;
Liu, Jie;
Gantz, Ira;
Derosa, Giuseppe

Publication type:

Article

Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV.

Published in:

Diabetes Therapy, 2021, v. 12, n. 4, p. 1175, doi. 10.1007/s13300-021-01018-w

By:

Strojek, Krzysztof;
Pandey, A. Shekhar;
Dell, Vanessa;
Sisson, Melanie;
Wang, Shuai;
Huyck, Susan;
Liu, Jie;
Gantz, Ira

Publication type:

Article

Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials.

Published in:

Diabetes Therapy, 2020, v. 11, n. 6, p. 1347, doi. 10.1007/s13300-020-00803-3

By:

Patel, Shrita;
Hickman, Anne;
Frederich, Robert;
Johnson, Susan;
Huyck, Susan;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case–Control Study.

Published in:

Diabetes Therapy, 2020, v. 11, n. 3, p. 711, doi. 10.1007/s13300-020-00771-8

By:

Wang, Tongtong;
Patel, Shrita M.;
Hickman, Anne;
Liu, Xinyue;
Jones, Philip LStJ;
Gantz, Ira;
Koro, Carol E.

Publication type:

Article

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control.

Published in:

Diabetes Therapy, 2017, v. 8, n. 4, p. 793, doi. 10.1007/s13300-017-0270-7

By:

Gantz, Ira;
Okamoto, Taro;
Ito, Yuka;
Sato, Asako;
Okuyama, Kotoba;
O'Neill, Edward;
Engel, Samuel;
Lai, Eseng

Publication type:

Article

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2015, v. 6, n. 1, p. 75, doi. 10.1007/s13300-015-0094-2

By:

Hauber, A.;
Tunceli, Kaan;
Yang, Jui-Chen;
Gantz, Ira;
Brodovicz, Kimberly;
Alexander, Charles;
Davies, Michael;
Radican, Larry

Publication type:

Article

Effects of ertugliflozin on renal function over 104 weeks of treatment: a post hoc analysis of two randomised controlled trials.

Published in:

Diabetologia, 2020, v. 63, n. 6, p. 1128, doi. 10.1007/s00125-020-05133-4

By:

Cherney, David Z. I.;
Heerspink, Hiddo J. L.;
Frederich, Robert;
Maldonado, Mario;
Liu, Jie;
Pong, Annpey;
Xu, Zhi J.;
Patel, Shrita;
Hickman, Anne;
Mancuso, James P.;
Gantz, Ira;
Terra, Steven G.

Publication type:

Article

Loops and Links: Structural Insights into the Remarkable Function of the Agouti-Related Protein.

Published in:

Annals of the New York Academy of Sciences, 2003, v. 994, n. 1, p. 27, doi. 10.1111/j.1749-6632.2003.tb03159.x

By:

MILLHAUSER, GLENN L.;
McNULTY, JOE C.;
JACKSON, PILGRIM J.;
THOMPSON, DARREN A.;
BARSH, GREGORY S.;
GANTZ, IRA

Publication type:

Article

NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine.

Published in:

Obesity (19307381), 2007, v. 15, n. 8, p. 2027, doi. 10.1038/oby.2007.242

By:

Erondu, Ngozi;
Addy, Carol;
Kaifeng Lu;
Mallick, Madhuja;
Musser, Bret;
Gantz, Ira;
Proietto, Joseph;
Astrup, Arne;
Toubro, Søren;
Rissannen, Aila M.;
Tonstad, Serena;
Haynes, William G.;
Gottesdiener, Keith M.;
Kaufman, Keith D.;
Amatruda, John M.;
Heymsfield, Steven B.

Publication type:

Article

Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss.

Published in:

2007

By:

Erondu, Ngozi;
Wadden, Thomas;
Gantz, Ira;
Musser, Bret;
Nguyen, Allison Martin;
Bays, Harold;
Bray, George;
O'Neil, Patrick M.;
Basdevant, Arnaud;
Kaufman, Keith D.;
Heymsfield, Steven B.;
Amartruda, John M.;
Amatruda, John M

Publication type:

journal article

Fat and Energy Partitioning: Longitudinal Observations in Leptin-treated Adults Homozygous for a Lep Mutation<sup>*</sup>.

Published in:

Obesity (19307381), 2006, v. 14, n. 2, p. 258, doi. 10.1038/oby.2006.33

By:

Heymsfield, Steven B.;
Fong, Tung M.;
Gantz, Ira;
Erondu, Ngozi

Publication type:

Article

A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy.

Published in:

2017

By:

Handelsman, Yehuda;
Lauring, Brett;
Gantz, Ira;
Iredale, Carol;
O’Neill, Edward A.;
Wei, Ziwen;
Suryawanshi, Shailaja;
Kaufman, Keith D.;
Engel, Samuel S.;
Lai, Eseng;
O'Neill, Edward A

Publication type:

journal article

A randomized clinical trial evaluating the efficacy and safety of the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy.

Published in:

2017

By:

Shankar, R. Ravi;
Inzucchi, Silvio E.;
Scarabello, Victoria;
Gantz, Ira;
Kaufman, Keith D.;
Lai, Eseng;
Ceesay, Paulette;
Suryawanshi, Shailaja;
Engel, Samuel S.

Publication type:

journal article

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes.

Published in:

Patient Preference & Adherence, 2013, v. 7, p. 937, doi. 10.2147/PPA.S43465

By:

Hauber, A. Brett;
Han, Steven;
Jui-Chen Yang;
Gantz, Ira;
Tunceli, Kaan;
Gonzalez, Juan Marcos;
Brodovicz, Kimberly;
Alexander, Charles M.;
Davies, Michael;
Iglay, Kristy;
Qiaoyi Zhang;
Radican, Larry

Publication type:

Article

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus.

Published in:

Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0593-8

By:

Gantz, Ira;
Menghui Chen;
Suryawanshi, Shailaja;
Ntabadde, Catherine;
Shah, Sukrut;
O'Neill, Edward A.;
Engel, Samuel S.;
Kaufman, Keith D.;
Eseng Lai

Publication type:

Article

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial.

Published in:

European Journal of Heart Failure, 2025, v. 27, n. 3, p. 521, doi. 10.1002/ejhf.3511

By:

Pandey, Ambarish;
Kolkailah, Ahmed A.;
McGuire, Darren K.;
Frederich, Robert C.;
Cater, Nilo B.;
Cosentino, Francesco;
Pratley, Richard E.;
Dagogo‐Jack, Samuel;
Cherney, David Z.I.;
Wynant, Willy;
Gantz, Ira;
Mancuso, James P.;
Masiukiewicz, Urszula;
Cannon, Christopher P.

Publication type:

Article

A randomized clinical trial evaluating the safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control.

Published in:

Journal of Diabetes, 2016, v. 8, n. 5, p. 701, doi. 10.1111/1753-0407.12351

By:

Moses, Robert G.;
Round, Elizabeth;
Shentu, Yue;
Golm, Gregory T.;
O'neill, Edward A.;
Gantz, Ira;
Engel, Samuel S.;
Kaufman, Keith D.;
Goldstein, Barry J.

Publication type:

Article

796-P: Cardiorenal Outcomes with Ertugliflozin by Baseline Cardiorenal Medications: An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-796-P

By:

CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
PRATLEY, RICHARD E.;
SHIH, WEICHUNG J.;
MALDONADO, MARIO;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
MASIUKIEWICZ, URSZULA;
CANNON, CHRISTOPHER P.

Publication type:

Article

786-P: Glycemic Efficacy and Safety of Ertugliflozin (ERTU) in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease Stage 3 (CKD 3): An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-786-P

By:

DAGOGO-JACK, SAMUEL;
PRATLEY, RICHARD E.;
CHERNEY, DAVID;
CHARBONNEL, BERNARD;
MCGUIRE, DARREN K.;
COSENTINO, FRANCESCO;
SHIH, WEICHUNG J.;
LIU, JIE;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
RAJI, ANNASWAMY;
GANTZ, IRA

Publication type:

Article

785-P: Ertugliflozin (ERTU) Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients with Type 2 Diabetes (T2D): An Analysis From VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-785-P

By:

DAGOGO-JACK, SAMUEL;
FREDERICH, ROBERT;
CHARBONNEL, BERNARD;
LIU, JIE;
CANNON, CHRISTOPHER P.;
SHI, HARRY;
MCGUIRE, DARREN K.;
CHERNEY, DAVID;
COSENTINO, FRANCESCO;
SHIH, WEICHUNG J.;
MASIUKIEWICZ, URSZULA;
GANTZ, IRA;
PRATLEY, RICHARD E.

Publication type:

Article

783-P: Cardiorenal Outcomes with Ertugliflozin by Baseline (BL) Glucose-Lowering Agent (GLA): An Analysis from VERTIS CV.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-783-P

By:

CHARBONNEL, BERNARD;
DAGOGO-JACK, SAMUEL;
CANNON, CHRISTOPHER P.;
CHERNEY, DAVID;
COSENTINO, FRANCESCO;
MCGUIRE, DARREN K.;
SHIH, WEICHUNG J.;
LIU, JIE;
PONG, ANNPEY;
GANTZ, IRA;
FREDERICH, ROBERT;
MANCUSO, JAMES P.;
PRATLEY, RICHARD E.

Publication type:

Article

1258-P: Physician Survey on Discontinuing Dipeptidyl Peptidase-4 Inhibitors (DPP-4is) following Insulin Initiation in Patients with Type 2 Diabetes (T2D) in the U.S.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1258-P

By:

FERNANDES, GAIL;
JAFFE, DENA H.;
BEYER, GRACE DIBONAVENTURA;
MATOS, JOANA E.;
IGLAY, KRISTY;
GANTZ, IRA;
RAJPATHAK, SWAPNIL

Publication type:

Article

1210-P: Pooled Analysis of the Safety and Efficacy of Ertugliflozin in the Elderly.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1210-P

By:

PRATLEY, RICHARD E.;
DAGOGO-JACK, SAMUEL;
CHARBONNEL, BERNARD;
PATEL, SHRITA M.;
HICKMAN, MARY A.;
LIU, JIE;
TARASENKO, LISA;
ELLISON, MISOO C.;
GANTZ, IRA;
TERRA, STEVEN G.

Publication type:

Article

1197-P: Two-Year Effects of Ertugliflozin on Renal Function.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1197-P

By:

CHERNEY, DAVID;
HEERSPINK, HIDDO L.;
FREDERICH, ROBERT;
MALDONADO, MARIO;
PONG, ANNPEY;
XU, ZHI JIN;
LIU, JIE;
MANCUSO, JAMES P.;
GANTZ, IRA;
TERRA, STEVEN G.

Publication type:

Article

2353-PUB: Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM).

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2353-PUB

By:

LIU, JIE;
TARASENKO, LISA;
ELLISON, MISOO C.;
PONG, ANNPEY;
HUYCK, SUSAN;
MANCUSO, JAMES P.;
TERRA, STEVEN G.;
GANTZ, IRA

Publication type:

Article

A randomised, double-blind, trial of the safety and efficacy of omarigliptin (a once-weekly DPP-4 inhibitor) in subjects with type 2 diabetes and renal impairment.

Published in:

2017

By:

Chacra, Antonio;
Gantz, Ira;
Mendizabal, Geraldine;
Durlach, Lucila;
O'Neill, Edward A.;
Zimmer, Zachary;
Suryawanshi, Shailaja;
Engel, Samuel S.;
Lai, Eseng

Publication type:

journal article

Randomized, controlled, double-blind trial of taranabant for smoking cessation.

Published in:

Psychopharmacology, 2010, v. 209, n. 3, p. 245, doi. 10.1007/s00213-010-1790-2

By:

Morrison, Mary;
Ceesay, Paulette;
Gantz, Ira;
Kaufman, Keith;
Lines, Christopher

Publication type:

Article

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 8, p. 2042, doi. 10.1210/clinem/dgac764

By:

Dagogo-Jack, Samuel;
Frederich, Robert;
Jie Liu;
Cannon, Christopher P.;
Shi, Harry;
Cherney, David Z. I.;
Cosentino, Francesco;
Masiukiewicz, Urszula;
Gantz, Ira;
Pratley, Richard E.

Publication type:

Article